Fluoroscopy Equipment Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Type (Fixed C-arms, Fluoroscopy Systems, Remote Controlled Systems, Patient-Side Controlled Systems, Others), By Application (Diagnostics {Cardiology, Gastroenterology, Urology & Nephrology, Others}, Surgical {Orthopedic & Trauma Surgeries, Neurosurgeries, Cardiovascular Surgeries, Others}), By End User (Hospitals & Clinics, Diagnostic Imaging Centers, Others), By Region & Competition, 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 6.79 Billion
CAGR (2026-2031)	3.57%
Fastest Growing Segment	Fluoroscopy Systems
Largest Market	North America
Market Size (2031)	USD 8.38 Billion

Market Overview

The Global Fluoroscopy Equipment Market is projected to grow from USD 6.79 Billion in 2025 to USD 8.38 Billion by 2031 at a 3.57% CAGR. Fluoroscopy equipment, a medical imaging modality, utilizes X-rays to generate real-time, dynamic images of the body's internal structures, enabling clinicians to visualize organ function, guide interventional procedures, and aid in diagnosis. The global market for this equipment is primarily driven by the increasing prevalence of chronic conditions such as cardiovascular and orthopedic disorders, alongside a growing demand for minimally invasive surgical techniques that rely on live imaging guidance. Additionally, an aging global population contributes significantly to the demand for diagnostic and interventional procedures, further propelling market expansion.

A significant challenge impeding market growth is the persistent concern regarding radiation exposure for both patients and healthcare professionals, despite ongoing advancements in dose reduction technologies. The high capital investment required for advanced fluoroscopy systems and stringent regulatory frameworks also represent considerable barriers to adoption. According to the American College of Radiology (ACR), in April 2025, its Appropriateness Criteria update included 257 diagnostic imaging and interventional radiology topics, covering nearly 3,700 clinical scenarios, underscoring the broad application and continuous development within the imaging field that fluoroscopy systems serve.

Key Market Drivers

The global fluoroscopy equipment market is significantly influenced by the rising demand for minimally invasive procedures, which require real-time imaging for precise guidance. These procedures offer numerous benefits, including reduced patient trauma, shorter hospital stays, and quicker recovery times, making them increasingly preferred over traditional open surgeries. Fluoroscopy systems are integral to a wide array of such interventions, including cardiovascular, orthopedic, and gastrointestinal applications, by providing dynamic visualization of internal structures during complex medical interventions. This persistent preference for less invasive techniques directly translates into a greater need for advanced fluoroscopy devices that support enhanced procedural accuracy and patient outcomes. According to Siemens Healthineers, in its Q4 Fiscal Year 2025 report published November 2025, the Advanced Therapies segment, which includes interventional systems essential for minimally invasive procedures, achieved a comparable revenue growth of 3.8%.

Further propelling the market is continuous advancements in fluoroscopy imaging technology, addressing critical concerns such as radiation exposure while enhancing diagnostic capabilities. Innovations focus on improving image quality, reducing dose, and integrating artificial intelligence for more efficient workflows and accurate real-time analysis. Such technological progress expands the utility of fluoroscopy systems, making them safer and more effective for a broader range of clinical applications. According to an article by Impending.ai in June 2025, Philips claims its updated imaging approach may cut radiation exposure by up to 50% compared to current lowest-dose settings, highlighting a significant technological advancement. This ongoing development, alongside robust industry performance, underpins the market's trajectory. According to AuntMinnie.com, in November 2025, Siemens Healthineers reported its full fiscal year 2025 revenues rose to €23.375 billion.

Download Free Sample Report

Key Market Challenges

The persistent concern surrounding radiation exposure for both patients and healthcare professionals significantly impedes the growth of the global fluoroscopy equipment market. This challenge directly influences clinical practices and regulatory environments, fostering a demand for systems with advanced dose reduction technologies. Patient apprehension regarding cumulative radiation doses can lead to reduced willingness for repeated or prolonged fluoroscopic procedures.

Heightened regulatory scrutiny and the implementation of more stringent reporting requirements further escalate the financial and administrative burden on healthcare providers. For instance, at the European Congress of Radiology 2026, it was noted that starting in 2025, Finland initiated mandatory reporting of preventive actions taken in response to radiation safety deviations in x-ray practices, with approximately 12,920 deviations reported since 2015. Such mandates compel investments in upgraded equipment, comprehensive staff training, and robust dose management systems, contributing to higher operational costs and thus slowing the adoption rate of new fluoroscopy systems.

Key Market Trends

The increasing deployment of mobile C-arms represents a significant trend in the fluoroscopy equipment market, primarily due to their versatility in facilitating image-guided procedures across various clinical settings. These portable systems enhance workflow efficiency and patient care by providing real-time imaging directly at the point of need, reducing patient transport and supporting the expansion of minimally invasive surgeries. This accessibility improves procedural efficiency and patient outcomes. According to GE HealthCare, in its Q4 2025 financial results published in February 2026, its Imaging segment, encompassing fluoroscopy systems, achieved an organic revenue growth of 5.3%.

The growth in aftermarket services and software enhancements also profoundly impacts the global fluoroscopy equipment market, as it extends the lifespan and enhances the capabilities of installed systems. This trend includes maintenance, calibration, software upgrades for improved image processing, and cybersecurity solutions, all of which ensure optimal performance and regulatory compliance. These services allow healthcare providers to maximize their return on investment and adapt to evolving clinical demands without full hardware replacements. According to GE HealthCare, in its Q4 2025 financial results published in February 2026, its Advanced Visualization Solutions segment, which offers software and related services, recorded an organic revenue growth of 4.2%.

Segmental Insights

The Fluoroscopy Systems segment is currently the fastest-growing area within the Global Fluoroscopy Equipment Market. This significant expansion is predominantly fueled by the increasing demand for real-time imaging capabilities crucial for diagnostic and interventional procedures. Rapid technological advancements, including the integration of digital imaging, flat-panel detectors, and sophisticated image processing software, greatly enhance image quality and optimize radiation dose management, thereby improving both patient safety and clinical efficacy. Furthermore, the rising global incidence of chronic diseases, such as cardiovascular and orthopedic conditions, drives the adoption of minimally invasive surgical techniques, where fluoroscopy systems provide essential precision and guidance for clinicians.

Regional Insights

North America stands as a dominant force in the global fluoroscopy equipment market, driven by several key factors. The region benefits from a well-established healthcare infrastructure and a high adoption rate of advanced medical technologies. This is complemented by the significant prevalence of chronic diseases, particularly cardiovascular and respiratory conditions, which necessitate sophisticated diagnostic and interventional imaging solutions. Moreover, North America's market strength is reinforced by efficient regulatory frameworks, such as those upheld by the Food and Drug Administration, ensuring product safety and efficacy. Additionally, robust reimbursement policies and the presence of prominent market players contribute to the region's continued leadership and technological innovation.

Recent Developments

• In March 2026, Orthoscan, a division of Ziehm-Orthoscan, Inc., debuted its TAU MVP at the American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting. This breakthrough mini C-arm was the first to merge fluoroscopy and arthroscopy into a single mobile imaging platform. The TAU MVP provided simultaneous fluoroscopy and arthroscopy views, offering surgeons deeper insight and immediate clarity during orthopedic procedures. This integrated system aimed to improve surgical precision by providing a comprehensive view of joint structures and motion, thereby transforming how orthopedic imaging and guidance were approached in surgical settings.
• In November 2025, Canon Medical Systems USA announced that its Alphenix / Evolve Edition with αEvolve Imaging had received FDA 510(k) clearance. This innovation in interventional cardiology imaging utilized deep learning technology to enhance fluoroscopic image quality during percutaneous coronary interventions (PCI). The αEvolve Imaging employed deep learning-based noise reduction and multi-frequency processing, delivering sharp and clear fluoroscopic images. Additionally, the Dynamic Device Stabilizer, also trained with deep learning, automatically detected and stabilized balloon markers, assisting in stent visualization during complex PCI procedures and supporting critical diagnostic decisions.
• In July 2025, Siemens Healthineers received FDA clearance for two new multifunctional imaging platforms: the remote-controlled Luminos Q.namix R and the Luminos Q.namix T with tableside control. These systems were designed to perform both radiography and fluoroscopy, simplifying workflows while maintaining low patient radiation doses. The platforms featured intuitive controls, integrated components, and built-in workflow guidance supported by artificial intelligence. Siemens Healthineers developed these platforms with input from numerous fluoroscopy experts to ensure a user-friendly design and enhanced efficiency for specialized and complex examinations, aiming to reduce patient wait times.
• In March 2025, Canon Medical Systems USA announced the U.S. market launch of its Adora DRFi, a hybrid imaging system designed for radiography and fluoroscopy in a single solution. The Adora DRFi, which received FDA 510(k) clearance in December 2024, aimed to enhance workflow efficiency and equipment utilization for healthcare providers. This system incorporated PositionAnywhere technology, allowing the unit to adjust to the patient, thereby reducing patient repositioning. It also featured a new CXDI-RF Wireless B1 Detector for seamless imaging and a durable patient table with extensive rotation capabilities, optimizing access and flexibility for various procedures.

Key Market Players

• Siemens Healthineers AG
• GE Healthcare
• Koninklijke Philips N.V.
• Canon Medical Systems Corporation
• Medtronic Plc.
• Hologic, Inc.
• Shimadzu Corporation
• Hitachi, Ltd.
• Carestream Health, Inc.
• Allengers Medical Systems Limited

By Type	By Application	By End User	By Region
Fixed C-arms Fluoroscopy Systems Remote Controlled Systems Patient-Side Controlled Systems Others	Diagnostics {Cardiology Gastroenterology Urology & Nephrology Others} Surgical {Orthopedic & Trauma Surgeries Neurosurgeries Cardiovascular Surgeries Others}	Hospitals & Clinics Diagnostic Imaging Centers Others	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Fluoroscopy Equipment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Fluoroscopy Equipment Market, By Type:

• Fixed C-arms
• Fluoroscopy Systems
• Remote Controlled Systems
• Patient-Side Controlled Systems
• Others

• Fluoroscopy Equipment Market, By Application:

• Diagnostics {Cardiology
• Gastroenterology
• Urology & Nephrology
• Others}
• Surgical {Orthopedic & Trauma Surgeries
• Neurosurgeries
• Cardiovascular Surgeries
• Others}

• Fluoroscopy Equipment Market, By End User:

• Hospitals & Clinics
• Diagnostic Imaging Centers
• Others

• Fluoroscopy Equipment Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE